尼瓦布帕和帕拉斯医疗获得了SEBI的IPO批准,目标分别是筹集3000亿卢比和400亿卢比. Niva Bupa and Paras Healthcare receive SEBI approval for IPOs, aiming to raise ₹3,000 crore and ₹400 crore, respectively.

印度证券交易委员会 (SEBI) 已批准了Niva Bupa健康保险和Paras健康保险的首次公开募股. Niva Bupa Health Insurance and Paras Healthcare have received approval from India's Securities and Exchange Board (SEBI) for their initial public offerings (IPOs). 尼瓦布帕的目标是筹集3000亿卢比,而帕拉斯则是400亿卢比. Niva Bupa aims to raise ₹3,000 crore, while Paras targets ₹400 crore. 这两项投资促进方案都将包括新的股本和出售提议。 Both IPOs will include fresh equity and an Offer for Sale. 资金将用于加强资本基础和一般公司目的。 Funds will be used to strengthen capital bases and for general corporate purposes. Niva Bupa是一家主要的健康保险公司,在市场上占有相当大的份额,采用数字第一战略。 Niva Bupa is a leading health insurer with a significant market share and a digital-first strategy.